Copyright
©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 21, 2014; 20(3): 613-629
Published online Jan 21, 2014. doi: 10.3748/wjg.v20.i3.613
Published online Jan 21, 2014. doi: 10.3748/wjg.v20.i3.613
AID or AID-related disorders linked to H. pylori | AID or AID-related disorders linked to H. pylori | ||
1 | Alopecia areata | 49 | Juvenile diabetes (Type 1 diabetes) |
2 | Antiphospholipid syndrome | 50 | Kawasaki syndrome |
3 | Autoimmune angioedema | 51 | Leukocytoclastic vasculitis |
4 | Autoimmune hepatitis | 52 | Lichen planus |
5 | Autoimmune hyperlipidemia | 53 | Linear IgA disease |
6 | Autoimmune hemolytic anemia | 54 | Lupus (SLE) |
7 | Autoimmune myocarditis | 55 | Microscopic polyangiitis |
8 | Autoimmune oophoritis | 56 | Mixed connective tissue disease |
9 | Autoimmune pancreatitis | 57 | Mooren’s ulcer |
10 | Autoimmune polyglandular syndromes | 58 | Multiple sclerosis |
11 | Autoimmune thrombocytopenic purpura | 59 | Myositis |
12 | Autoimmune thyroid disease | 60 | Narcolepsy |
13 | Autoimmune urticaria | 61 | Neuromyelitis optica (Devic’s) |
14 | Axonal and neuronal neuropathies | 62 | Neutropenia |
15 | Behcet’s disease | 63 | Ocular cicatricial pemphigoid |
16 | Bullous pemphigoid | 64 | Optic neuritis |
17 | Cardiomyopathy | 65 | Palindromic rheumatism |
18 | Celiac disease | 66 | Pars planitis (peripheral uveitis) |
19 | Chagas disease | 67 | Pemphigus |
20 | Chronic inflammatory demyelinating polyneuropathy | 68 | Peripheral neuropathy |
21 | Chronic recurrent multifocal osteomyelitis | 69 | Perivenous encephalomyelitis |
22 | Crohn’s disease | 70 | Pernicious anemia |
23 | Cogans syndrome | 71 | Polyarteritis nodosa |
24 | Demyelinating neuropathies | 72 | Polymyalgia rheumatica |
25 | Dermatitis herpetiformis | 73 | Polymyositis |
26 | Dermatomyositis | 74 | Primary biliary cirrhosis |
27 | Devic’s disease (neuromyelitis optica) | 75 | Primary sclerosing cholangitis |
28 | Eosinophilic esophagitis | 76 | Psoriasis |
29 | Eosinophilic fasciitis | 77 | (Idiopathic) pulmonary fibrosis |
30 | Erythema nodosum | 78 | Pyoderma gangrenosum |
31 | Experimental allergic encephalomyelitis | 79 | Raynaud’s phenomenon |
32 | Fibromyalgia | 80 | Reactive Arthritis |
33 | Fibrosing alveolitis | 81 | Reiter’s syndrome |
34 | Giant cell arteritis (temporal arteritis) | 82 | Relapsing polychondritis |
35 | Giant cell myocarditis | 83 | Rheumatoid arthritis |
36 | Glomerulonephritis | 84 | Sarcoidosis |
37 | Goodpasture’s syndrome | 85 | Scleroderma (systemic sclerosis) |
38 | Graves’ disease | 86 | Sjogren’s syndrome |
39 | Guillain-Barre syndrome | 87 | Temporal arteritis/Giant cell arteritis |
40 | Hashimoto’s thyroiditis | 88 | Thrombocytopenic purpura |
41 | Henoch-Schonlein purpura | 89 | Transverse myelitis |
42 | Hypogammaglobulinemia idiopathic thrombocytopenic purpura | 90 | Type 1 diabetes |
43 | IgA nephropathy | 91 | Ulcerative colitis |
44 | IgG4-related sclerosing disease | 92 | Undifferentiated connective tissue disease |
45 | Immunoregulatory lipoproteins | 93 | Uveitis |
46 | Inclusion body myositis | 94 | Vasculitis (other forms) |
47 | Interstitial cystitis | 95 | Vesiculobullous dermatosis |
48 | Juvenile arthritis |
AID or AID-related disorders not linked to H. pylori | |
1 | Acute Disseminated Encephalomyelitis |
2 | Acute necrotizing hemorrhagic leukoencephalitis |
3 | Addison's disease |
4 | Agammaglobulinemia |
5 | Amyloidosis |
6 | Ankylosing spondylitis |
7 | Anti-GBM/Anti-TBM nephritis |
8 | Autoimmune aplastic anemia |
9 | Autoimmune dysautonomia |
10 | Autoimmune immunodeficiency |
11 | Autoimmune inner ear disease |
12 | Autoimmune retinopathy |
13 | Balo disease |
14 | Castleman disease |
15 | Chronic fatigue syndrome |
16 | Churg-Strauss syndrome |
17 | Cicatricial pemphigoid/benign mucosal pemphigoid |
18 | Congenital heart block |
19 | Coxsackie myocarditis |
20 | CREST disease |
21 | Essential mixed cryoglobulinemia |
22 | Discoid lupus |
23 | Dressler’s syndrome |
24 | Endometriosis |
25 | Evans syndrome |
26 | Granulomatosis with Polyangiitis (formerly called Wegener’s Granulomatosis) |
27 | Hashimoto’s encephalitis |
28 | Herpes gestationis |
29 | Juvenile myositis |
30 | Lambert-Eaton syndrome |
31 | Lichen sclerosus |
32 | Ligneous conjunctivitis |
33 | Lyme disease, |
34 | (Chronic) Meniere’s disease |
35 | Mucha-Habermann disease |
36 | Myasthenia gravis |
37 | Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus |
38 | Paraneoplastic cerebellar degeneration |
39 | Paroxysmal nocturnal hemoglobinuria |
40 | Parry Romberg syndrome |
41 | Parsonage-Turner syndrome |
42 | POEMS syndrome |
43 | Postmyocardial infarction syndrome |
44 | Postpericardiotomy syndrome |
45 | Progesterone dermatitis |
46 | Psoriatic arthritis |
47 | Pure red cell aplasia |
48 | Reflex sympathetic dystrophy |
49 | Restless legs syndrome |
50 | Retroperitoneal fibrosis |
51 | Rheumatic fever |
52 | Schmidt syndrome |
53 | Scleritis |
54 | Sperm and testicular autoimmunity |
55 | Stiff person syndrome |
56 | Subacute bacterial endocarditis |
57 | Susac’s syndrome |
58 | Sympathetic ophthalmia |
59 | Takayasu’s arteritis |
60 | Tolosa-Hunt syndrome |
61 | Vitiligo |
Autoimmune condition | Evidence in support and/or against the role of H. pylori | Overall opinion |
SjS | Support: | Inconclusive |
Oral cavity populated with H. pylori | ||
Higher level of anti-H. pylori antibodies in SjS patients | ||
Increased incidence of mucosal associated lymphoid tissue and lymphomas in parotid and lacrimal glands of SjS patients | ||
Against: | ||
Low levels of anti-H. pylori antibodies in SjS patients compared to controls | ||
SSc | Support: | Inconclusive |
Higher incidence of H. pylori antibodies in SSc patients than controls | ||
H. pylori eradication improves Raynaud's in SSc patients | ||
Possible protective role against Barrett's esophagus | ||
Higher level of CagA strain H. pylori infected patients | ||
Against: | ||
Low incidence of anti-H. pylori antibodies compared to controls | ||
RA | Support: | Unlikely |
Increased rheumatoid factor IgM from B cells chronically stimulated with H. pylori urease | ||
Against: | ||
Low prevalence of anti-H. pylori in RA patients | ||
Unchanged clinical course or symptomatology after H. pylori eradication | ||
SLE | Support: | Unlikely |
H. pylori urease exposure induced anti-ssDNA antibody production in an animal model of SLE | ||
Against: | ||
Low levels of anti-H. pylori found among SLE patients, at levels comparable to controls | ||
Negative association between H. pylori seropositivity and the development of SLE in African-American women | ||
ITP | Support: | Probable |
Improvement of platelet counts following H. pylori eradication (CagA type H. pylori in particular) | ||
Anti-CagA antibodies cross-react with peptides on platelets of ITP patient | ||
Platelet associated IgGs declined following H. pylori eradication | ||
Found in high prevalence in some ITP cohorts | ||
Platelet eluates from ITP patients recognize H. pylori CagA | ||
Against: | ||
Low levels of H. pylori found in ITP patients | ||
AiTD | Support: | Probable in Graves’ disease |
Higher seropositivity and positive stool cultures for H. pylori in Graves’ disease patients | ||
CagA strain predominant among Graves’ disease patients | ||
Amino acid similarities between CagA and thyroid peroxidase | ||
Reduction in anti-thyroid antibodies following H. pylori eradication | ||
Against: | Unlikely in Hashimoto’s thyroiditis | |
Low levels of infection among Hashimoto’s thyroiditis patients | ||
MS and NMO | Support: | Probable in NMO |
High rate of H. pylori infection among NMO patients | ||
Correlation between H. pylori infection and presence of aquaporin-4 antibodies | ||
Against: | Unlikely in MS | |
H. pylori infection rates in MS patients similar to or lower than control groups | ||
Psoriasis | Support: | Probable |
Higher levels of anti-H. pylori antibodies in patients | ||
Appears to be correlation between H. pylori infection and disease severity | ||
Clinical improvement following H. pylori eradication | ||
Against: | ||
No difference in anti-H. pylori levels compared to controls | ||
No difference of CagA seropositivity between patients and controls | ||
Behçet’s disease | Support: | Unlikely |
Higher infection prevalence in patients | ||
Some clinical improvement noted after eradication | ||
Against: | ||
No difference between patients and controls | ||
Alopecia areata | Support: | Unlikely |
Higher infection prevalence | ||
Against: | ||
No difference in infection prevalence between patients and controls | ||
PBC | Support: | Unlikely |
Higher prevalence of anti-H. pylori antibodies among PBC patients | ||
Amino acid similarities between pyruvate dehydrogenase E2 (PDC-E2) and urease beta of H. pylori | ||
Against: | ||
No differences of infection found between patients and controls | ||
No immunological cross reactivities at the B or CD4 T-cell level | ||
No crossreactivity between H. pylori VacA and PDC-E2 | ||
AIH | Support: | Unlikely |
No current evidence | ||
Against: | ||
No differences in anti-H. pylori antibodies between patients and controls | ||
No significant difference between H. pylori in liver tissues in patients compared to controls | ||
PSC | Support: | Unlikely |
Detectable H. pylori DNA in PSC liver samples | ||
CagA in samples from PSC patients | ||
Concomitant ulcerative colitis may be related to H. pylori translocation from the gut to the liver | ||
Against: | ||
No difference in H. pylori prevalence among pediatric or adult PSC patients compared to controls | ||
No significant difference between H. pylori in liver tissues in patients compared to controls |
-
Citation: Smyk DS, Koutsoumpas AL, Mytilinaiou MG, Rigopoulou EI, Sakkas LI, Bogdanos DP.
Helicobacter pylori and autoimmune disease: Cause or bystander. World J Gastroenterol 2014; 20(3): 613-629 - URL: https://www.wjgnet.com/1007-9327/full/v20/i3/613.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i3.613